Machatha Stephen's Form 4/A amendment
AmendedAldeyra Therapeutics, Inc. (ALDX) · filed Apr 17, 2024
- Accession no.
- 0000950170-24-045113
- Filed
- Apr 17, 2024
- Trade date
- Mar 12, 2024
- Filing delay
- 36 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 12, 2024
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $36.5K. It was filed 36 days after the trade.
This amendment replaces 0000950170-24-030311 (filed Mar 12, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Machatha StephenCIK 0001836354 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | Common Stock | SSaleDisposed | −11,537 | $3.16 | −$36,456.92 | 252,812 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.